Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Mar;90(1071):20160836.
doi: 10.1259/bjr.20160836. Epub 2017 Jan 20.

Evaluation of 99mTc-MIBI in thyroid gland imaging for the diagnosis of amiodarone-induced thyrotoxicosis

Junqi Wang  1 , Ruiguo Zhang  1
Affiliations

Evaluation of 99mTc-MIBI in thyroid gland imaging for the diagnosis of amiodarone-induced thyrotoxicosis

Junqi Wang et al. Br J Radiol. 2017 Mar.

Abstract

Objective: Amiodarone-induced thyrotoxicosis (AIT) is caused by amiodarone as a side effect of cardiovascular disease treatment. Based on the differences in their pathological and physiological mechanisms, many methods have been developed so far to differentiate AIT subtypes such as colour flow Doppler sonography (CFDS) and 24-h radioiodine uptake (RAIU). However, these methods suffer from inadequate accuracy in distinguishing different types of AITs and sometimes lead to misdiagnosis and delayed treatments. Therefore, there is an unmet demand for an efficient method for accurate classification of AIT.

Methods: Technetium-99 methoxyisobutylisonitrile (99mTc-MIBI) thyroid imaging was performed on 15 patients for AIT classification, and the results were compared with other conventional methods such as CFDS, RAIU and 99mTcO4 imaging.

Results: High uptake and retention of MIBI in thyroid tissue is characteristic in Type I AIT, while in sharp contrast, low uptake of MIBI in the thyroid tissue was observed in Type II AIT. Mixed-type AIT shows uptake value between Types I and II. MIBI imaging outperforms other methods with a lower misdiagnosis rate.

Conclusion: Among the methods evaluated, MIBI imaging enables an accurate identification of Type I, II and mixed-type AITs by showing distinct images for different types of AITs. The results obtained from our selected subjects revealed that MIBI imaging is a reliable method for diagnosis and classification of AITs and MIBI imaging has potential in the treatment of thyroid diseases. Advances in knowledge: 99mTc-MIBI imaging is a useful method for the diagnosis of AIT. It can distinguish different types of AITs especially for mixed-type AIT, which is usually difficult to treat. 99mTc-MIBI has potential advantages over conventional methods in the efficient treatment of AIT.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Technetium-99 methoxyisobutylisonitrile imaging of the thyroid for different types of amiodarone-induced thyrotoxicoses (AITs). (a) diffused obvious uptake of MIBI by thyroid tissue-clear imaging of the thyroid tissue, (b) no uptake of MIBI by thyroid tissue-no imaging of the thyroid tissue, (c) heterogeneous decrease uptake of MIBI by thyroid tissue.
See this image and copyright information in PMC

References

    1. Bogazzi F, Bartalena L, Martino E. Approach to the patient with amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab 2010; 95: 2529–35. doi: https://doi.org/10.1210/jc.2010-0180 - DOI - PubMed
    1. Cohen-Lehman J, Dahl P, Danzi S, Klein I. Effects of amiodarone therapy on thyroid function. Nat Rev Endocrinol 2010; 6: 34–41. doi: https://doi.org/10.1038/nrendo.2009.225 - DOI - PubMed
    1. van Erven L, Schalij MJ. Amiodarone: an effective antiarrhythmic drug with unusual side effects. Heart 2010; 96: 1593–600. doi: https://doi.org/10.1136/hrt.2008.152652 - DOI - PubMed
    1. Takeuchi D, Honda K, Shinohara T, Inai K, Toyohara K, Nakanishi T. Incidence, clinical course, and risk factors of amiodarone-induced thyroid dysfunction in japanese adults with congenital heart disease. Circ J 2015; 79: 1828–34. doi: https://doi.org/10.1253/circj.CJ-15-0042 - DOI - PubMed
    1. Bartalena L, Bogazzi F, Martino E. Amiodarone-induced thyrotoxicosis: a difficult diagnostic and therapeutic challenge. Clin Endocrinol (Oxf) 2002; 56: 23–4. doi: https://doi.org/10.1046/j.0300-0664.2001.01458.x - DOI - PubMed